Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Epidemiology and Risk Factors for the Development of Infectious Complications in Patients with Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America

Eloísa Riva, Virginia Bove, Jule Vasquez, Camila Peña, Cristian Seehaus, Cesar Samanez-Figari, Justina Bustos, Marcos Hernandez, Julio Fernandez, Rosa Oliday Rios, Yusaima Rodriguez, Irving Figueredo, Dorotea Fantl

Blood (2021) 138 (Supplement 1): 3768.

DOI: https://doi.org/10.1182/blood-2021-149636

Published: 2021

Journal Articles

Frequency and Survival of T-Cell Lymphomas in Peru: Initial Report of a Peruvian Registry Experience

Blood (2021) 138 (Supplement 1): 1374.

DOI: https://doi.org/10.1182/blood-2021-154330

Published: 2021

Journal Articles

Validation of FLIPI1, FLIPI2, PRIMA and POD24 in Patients with Extranodal Follicular Lymphoma: A Cohort from Two Cancer Centers in Peru

Jule F Vasquez, Alonso Diaz, Any S Mendoza, Carlos Barrionuevo, Cesar Samanez-Figari

Blood (2021) 138 (Supplement 1): 4505.

DOI: https://doi.org/10.1182/blood-2021-152623

Published: 2021

Journal Articles

Differences in the Distribution of Non-Hodgkin Lymphoma in Public Versus Private Institution in a Latin American Country: A Cohort of 5,807 Cases

Jule F Vasquez, Alonso Diaz, Any S Mendoza, Claudio Flores, Carlos Barrionuevo, Cesar Samanez-Figari

Blood (2021) 138 (Supplement 1): 4511.

DOI: https://doi.org/10.1182/blood-2021-154417

Published: 2021

Journal Articles

Follicular Lymphoma in a Single Cancer Center and Validation of FLIPI, FLIPI2, PRIMA and POD24 in Non-Caucasian Patients from Peru

Jule F Vasquez, Alonso Diaz, Any S Mendoza, Carlos Barrionuevo, Cesar Samanez-Figari

Blood (2021) 138 (Supplement 1): 4518.

DOI: https://doi.org/10.1182/blood-2021-149734

Published: 2021

Journal Articles

Clinical Characteristics and Survival of Non-Nasal Natural Killer/T-Cell Lymphoma from 2 Cancer Centers from Peru

Jule F Vasquez, Melanie Castro, Alonso Diaz, Carlos Barrionuevo, Cesar Samanez-Figari

Blood (2021) 138 (Supplement 1): 4535.

DOI: https://doi.org/10.1182/blood-2021-154256

Published: 2021

Journal Articles

Clinical Features and Outcome of HTLV-1 Carriers Diagnosed with Hodgkin Lymphoma in Peru: A Matched Cohort Study

Gustavo Sandival-Ampuero, MD, Ursula Aviles-Perez, Bryan Valcarcel, MD, Juan C Haro, MD, Daniela Dueñas, MD, Carlos Barrionuevo, MD, Cindy Alcarraz, MD, Sandro Casavilca, MD, Marco Villena, MD, Shirley Quintana, MD, Cesar Samanez-Figari, MD, Luis E Malpica Castillo, MD, Daniel J Enriquez, MD

Blood (2020) 136 (Supplement 1): 22–23.

DOI: https://doi.org/10.1182/blood-2020-138562

Published: 2020

Journal Articles

Clinical Characteristics and Outcome of Diffuse Large B Cell Lymphoma Among HTLV-1 Carriers in Peru: A Matched Cohort Study

Bryan Valcarcel, MD, Daniel J Enriquez, MD, Gustavo Sandival-Ampuero, MD, Ursula Aviles-Perez, Juan C Haro, MD, Cindy Alcarraz, MD, Shirley Quintana, MD, Marco Villena, MD, Daniela Dueñas, MD, Sandro Casavilca, MD, Carlos Barrionuevo, MD, Cesar Samanez-Figari, MD, Luis E Malpica Castillo, MD

Blood (2020) 136 (Supplement 1): 38–39.

DOI: https://doi.org/10.1182/blood-2020-142186

Published: 2020

Journal Articles

Real-World Data of Azacytidine Efficacy As Front-Line Treatment for AML Non-Eligible for Intensive Treatment and High-Risk MDS: A Peruvian Multicenter Study

Angela Arbizu-Chipana, MD, Daniel J Enriquez, MD, Mariano Lopez-Pereyra, MD, Claudio Flores, Msc, Tatiana Saldarriaga, MD, Melissa Morales-Coloma, MD, Lourdes Lopez, MD, Jule F Vasquez, MD, Shirley Quintana, MD, Antonio Carrasco, MD Msc, Cesar Samanez-Figari, MD

Blood (2020) 136 (Supplement 1): 40–41.

DOI: https://doi.org/10.1182/blood-2020-140650

Published: 2020

Journal Articles

Incidence and Outcome of Acute Myeloid Leukemia in Peru: An 11-Year Single Center Experience

Ali Al-kassab-Córdova, Lizbeth Lachira-Yparraguirre, Gustavo Sandival-Ampuero, MD, Katia Roque, MD, Emperatriz Ortega, MD, Sofia Lozano-Ballena, MD, Juan C Haro, MD, Shirley Quintana, MD, Marco Villena, MD, Greenlandia Ferreyros-Brandon, MD, Juan L Garcia-Leon, MD, Cesar Samanez-Figari, MD, Luis Malpica Castillo, MD, Daniel J Enriquez, MD

Blood (2020) 136 (Supplement 1): 28–29.

DOI: https://doi.org/10.1182/blood-2020-143373

Published: 2020

Journal Articles

Clinical Characteristics, Immunophenotype and Outcomes of Blastic Plasmacytoid Dendritic Cell Neoplasms in a Peruvian Cohort

Daniela Dueñas, MD, Elizabeth Cervantes, Daniel J Enriquez, MD, Claudio Flores, Msc, Carlos Barrionuevo, MD, Cindy Alcarraz, MD, Lourdes Lopez, MD, Shirley Quintana, MD, Jule F Vasquez, MD, Rosario Retamozo, MD, Judith Vidal, MD, Tatiana Saldarriaga, MD, Antonio A Carrasco-Yalán, MDMSc, Juan L Garcia-Leon, MD, Cesar Samanez-Figari, MD

Blood (2020) 136 (Supplement 1): 42–43.

DOI: https://doi.org/10.1182/blood-2020-143212

Published: 2020

Journal Articles

Impact of Mutated Genes By Next Generation Sequencing on Overall Survival in a Cohort of Peruvian Patients with AML/MDS

Antonio A Carrasco-Yalán, MDMSc, Joseph A. Pinto, Jorge J Valdés-Gómez, MD, Tatiana Saldarriaga, MD, Melissa Morales-Coloma, MD, John W Pando-Mayta, MT, Marylin Cuyutupac-Barja, MT, Paloma Arias-Arana, Natalia I Vigo-Ames, Angela Arbizu-Chipana, MD, Shirley Quintana, MD, Franco Doimi, MD, Cesar Samanez-Figari, MD, Juan Haro-Vargas, MD, Jorge Castillo-Aguirre, MDMSc,PhD, Marco Lopez, MD, Daniel J Enriquez, MD

Blood (2020) 136 (Supplement 1): 31.

DOI: https://doi.org/10.1182/blood-2020-141808

Published: 2020

Journal Articles

Frequency of IKZF1 Deletions in a Peruvian Population with B-Cell Acute Lymphoblastic Leukemia

Daniel J Enriquez, MD, Rachel J. Mitchell, MSc, Krisztina Zuborne Alapi, MSc, Elizabeth Cervantes, Karina Cancino, Jhoysi Casas, Bryan Valcarcel, MD, Gustavo Sandival, MD, Juan C Haro, MD, Cesar Samanez-Figari, MD, Arturo Zapata, MD, Juan L Garcia-Leon, MD, Adele K. Fielding, MBBS,PhDFRCP,FRCPath

Blood (2020) 136 (Supplement 1): 11.

DOI: https://doi.org/10.1182/blood-2020-137122

Published: 2020

Journal Articles

Brentuximab Vedotin Plus Chemotherapy As Pre-Autologous Stem Cell Transplantation Salvage Treatment in Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from Peru

Shirley Quintana, MD, Jule F Vasquez, MD, Lourdes Lopez, MD, Cindy Alcarraz, MD, Claudio Flores, Msc, Cesar Samanez-Figari, MD

Blood (2020) 136 (Supplement 1): 31–32.

DOI: https://doi.org/10.1182/blood-2020-142647

Published: 2020

Journal Articles

Clinicopathologic Comparison of Plasmablastic Lymphoma Patients According HIV-Status: Peruvian Experience

Jule F Vasquez, MD, Cesar Samanez-Figari, MD, Lourdes Lopez, MD, Shirley Quintana, MD, Rolig Aliaga, MD, Yinno Custodio, MD, Cindy Alcarraz, MD, Daniel J Enriquez, MD, Daniela Dueñas, MD, Antonio Carrasco, MD Msc, Claudio Flores, Msc, Carlos Barrionuevo, MD, Luis Cuellar, MD

Blood (2020) 136 (Supplement 1): 19.

DOI: https://doi.org/10.1182/blood-2020-142239

Published: 2020

Journal Articles

Prognostic Factors of Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Imitanib: A Peruvian Experience

José Revilla-López, MD, Luis Casanova-Márquez, MD, Cesar Samanez-Figari, MD, Shirley Quintana-Truyenque, MD, Kelly Meza-Capcha, Andrea Carolina Anampa-Guzmán

Blood (2016) 128 (22): 5444.

DOI: https://doi.org/10.1182/blood.V128.22.5444.5444

Published: 2016

NARROW

Epidemiology and Risk Factors for the Development of Infectious Complications in Patients with Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America

Frequency and Survival of T-Cell Lymphomas in Peru: Initial Report of a Peruvian Registry Experience

Validation of FLIPI1, FLIPI2, PRIMA and POD24 in Patients with Extranodal Follicular Lymphoma: A Cohort from Two Cancer Centers in Peru

Differences in the Distribution of Non-Hodgkin Lymphoma in Public Versus Private Institution in a Latin American Country: A Cohort of 5,807 Cases

Follicular Lymphoma in a Single Cancer Center and Validation of FLIPI, FLIPI2, PRIMA and POD24 in Non-Caucasian Patients from Peru

Clinical Characteristics and Survival of Non-Nasal Natural Killer/T-Cell Lymphoma from 2 Cancer Centers from Peru

Clinical Features and Outcome of HTLV-1 Carriers Diagnosed with Hodgkin Lymphoma in Peru: A Matched Cohort Study

Clinical Characteristics and Outcome of Diffuse Large B Cell Lymphoma Among HTLV-1 Carriers in Peru: A Matched Cohort Study

Real-World Data of Azacytidine Efficacy As Front-Line Treatment for AML Non-Eligible for Intensive Treatment and High-Risk MDS: A Peruvian Multicenter Study

Incidence and Outcome of Acute Myeloid Leukemia in Peru: An 11-Year Single Center Experience

Clinical Characteristics, Immunophenotype and Outcomes of Blastic Plasmacytoid Dendritic Cell Neoplasms in a Peruvian Cohort

Impact of Mutated Genes By Next Generation Sequencing on Overall Survival in a Cohort of Peruvian Patients with AML/MDS

Frequency of IKZF1 Deletions in a Peruvian Population with B-Cell Acute Lymphoblastic Leukemia

Brentuximab Vedotin Plus Chemotherapy As Pre-Autologous Stem Cell Transplantation Salvage Treatment in Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from Peru

Clinicopathologic Comparison of Plasmablastic Lymphoma Patients According HIV-Status: Peruvian Experience

Prognostic Factors of Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Imitanib: A Peruvian Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only